Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in XENON PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 375,166 shares of XENE (XENON PHARMACEUTICALS INC), worth $21.8M as of 2026-Q1. The position was increased (+1589x shares). XENE represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$21.8M
Current Shares
375,166
Total Value Change
+$15.5M
Total Shares Change
+212,700
Other major holders of XENE: FMR LLC, Avoro Capital Advisors LLC, BlackRock, Inc.
Increased |
| 375,166 |
+1589x |
| $21.8M |
| 0.0% |
| $43.79 |
46 |
| 2025-Q4 | New | 236 | - | $10,578 | 0.0% | $44.12 | 26 |
| 2025-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $39.06 | 0 |
| 2025-Q2 | Increased | 404,384 | +536.1% | $12.7M | 0.0% | $32.40 | 45 |
| 2025-Q1 | Decreased | 63,568 | -66.9% | $2.1M | 0.0% | $34.26 | 0 |
| 2024-Q4 | Increased | 191,852 | +17.9% | $7.5M | 0.0% | $38.53 | 32 |
| 2024-Q3 | Increased | 162,683 | +0.1% | $6.4M | 0.0% | $38.65 | 27 |
| 2024-Q2 | Increased | 162,466 | +109.7% | $6.3M | 0.0% | $38.99 | 44 |